Regeneron Pharmaceuticals (REGN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 348 |
| % of all portfolios: | 0.021% |
| Hold Price * : | $1051.24 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q3 2024 | |||||
| ≡ | Viking Global Investors | Buy | 49,870 | 0.19 | |
| Q4 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 1,758 | 0.03 | |
| Q3 2023 | |||||
| ≡ | Dodge & Cox | Add 0.47% | 7,200 | 0.01 | |
| Q2 2023 | |||||
| ≡ | Dodge & Cox | Add 0.36% | 5,600 | 0.00 | |
| Q1 2023 | |||||
| ≡ | Dodge & Cox | Add 8.30% | 118,200 | 0.11 | |
| Q3 2022 | |||||
| ≡ | Dodge & Cox | Add 6.17% | 82,800 | 0.08 | |
| Q1 2022 | |||||
| ≡ | Dodge & Cox | Add 1135.15% | 1,232,876 | 0.89 | |
| ≡ | Thomas Gayner - Markel Group | Add 1.26% | 1,000 | 0.01 | |
| Q4 2021 | |||||
| ≡ | Dodge & Cox | Buy | 108,609 | 0.07 | |
| ≡ | Thomas Gayner - Markel Group | Add 6.73% | 5,000 | 0.04 | |
| Q3 2021 | |||||
| ≡ | Thomas Gayner - Markel Group | Add 11.23% | 7,500 | 0.06 | |
| ≡ | Polen Capital Management | Buy | 2,155 | 0.00 | |
| ≡ | Lee Ainslie - Maverick Capital | Buy | 490 | 0.00 | |
| Q2 2021 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Add 1450.00% | 290,000 | 3.20 | |
| ≡ | Thomas Gayner - Markel Group | Add 46.81% | 21,300 | 0.15 | |
| Q1 2021 | |||||
| ≡ | Thomas Gayner - Markel Group | Buy | 45,500 | 0.30 | |
| Q4 2020 | |||||
| ≡ | Polen Capital Management | Add 3.36% | 65,147 | 0.07 | |
| Q3 2020 | |||||
| ≡ | Polen Capital Management | Add 5.05% | 93,123 | 0.14 | |
| ≡ | Lee Ainslie - Maverick Capital | Buy | 588 | 0.01 | |
| Q2 2020 | |||||
| ≡ | Polen Capital Management | Add 7.18% | 123,532 | 0.23 | |
| Q1 2020 | |||||
| ≡ | Polen Capital Management | Add 2.67% | 44,708 | 0.09 | |
| Q4 2019 | |||||
| ≡ | Polen Capital Management | Add 2.08% | 34,084 | 0.05 | |
| Q3 2019 | |||||
| ≡ | Polen Capital Management | Add 3.60% | 57,097 | 0.07 | |
| Q2 2019 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Add 44.19% | 190,000 | 1.30 | |
| Q2 2018 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Buy | 600,000 | 3.59 | |
| Q1 2011 | |||||
| ≡ | Dodge & Cox | Buy | 145,128 | 0.01 | |
| Q3 2010 | |||||
| ≡ | Seth Klarman - Baupost Group | Buy | 1,000,000 | 1.71 | |
| Q1 2009 | |||||
| ≡ | Bill & Melinda Gates Foundation Trust | Buy | 35,500 | 0.01 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.